Arthritis Society

Recent papers from Arthritis Society

1. Responsiveness of patient-reported outcomes by disease trajectory in systemic lupus erythematosusLara D. Veeken · 2026
2. Unity Through Rheumatic Diseases: A Youth-Led Model of Community, Connection, and ChangeThe Journal of Rheumatology · 2026
3. Reduction of CXCR3 + CCR6 + CD4 + T Cells and IL ‐17+ RORγt + CD4 + T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic TherapyACR Open Rheumatology · 2026
4. Exploring Decisional Factors to Include Approaches in a Patient Decision Aid for Juvenile Idiopathic Arthritis Symptom ManagementThe Journal of Rheumatology · 2026
5. Exploring Training Needs to Facilitate Shared Decision Making in Juvenile Idiopathic Arthritis Symptom Management and the Use of the JIA Option MapThe Journal of Rheumatology · 2026
6. Longitudinal ANA and ENA Dynamics in Preclinical Systemic Autoimmune Rheumatic Diseases: A Retrospective Cohort StudyThe Journal of Rheumatology · 2026
7. Characterizing Memory T Cells Associated with Systemic Lupus Erythematosus PathogenesisThe Journal of Rheumatology · 2026
8. Transition to Adulthood Through Coaching and Empowerment in Rheumatology (TRACER): Patient-Reported Outcomes of a Feasibility Randomized Controlled TrialThe Journal of Rheumatology · 2026
9. Alterations in Innate Immune Cells During the Progression of Systemic Autoimmune Rheumatic DiseasesThe Journal of Rheumatology · 2026
10. Patient Perspectives of the Barriers and Facilitators to Participating in Appointments by Choice: A Qualitative Study of a Patient-Initiated Follow-Up Implementation Pilot Using the Consolidated Framework for Implementation ResearchThe Journal of Rheumatology · 2026
11. Type I Interferons Promote Development of Flares in Systemic Lupus Erythematosus by Enhancing B-Cell Activation and Differentiation of Age-Associated B CellsThe Journal of Rheumatology · 2026
12. Co-Development and Evaluation of a Flare Action Plan for Rheumatoid ArthritisThe Journal of Rheumatology · 2026
13. Implementation of the Appointments by Choice Model for Rheumatoid Arthritis: A Patient-Initiated Follow-Up Pilot StudyThe Journal of Rheumatology · 2026
14. Characterizing Immune Cell Subsets and Interferon in the Kidneys of Lupus Nephritis PatientsThe Journal of Rheumatology · 2026
15. Number Needed to Screen for Axial Spondyloarthritis: Preliminary Results from the Fastrax CohortThe Journal of Rheumatology · 2026
16. Global research priorities for back pain, neck pain and osteoarthritis: a scoping reviewBMJ Open · 2026
17. Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real‐World Effectiveness and Safety From a Prospective CohortACR Open Rheumatology · 2026
18. Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 TrialArthritis & Rheumatology · 2026
19. Distinct trajectories of urbanization shape the human gut microbiome across South AsiaGut Microbes · 2026
20. Do Patients Diagnosed with Psoriatic Arthritis Before or Concurrently with Psoriasis Have Different Disease Phenotype and Outcomes?The Journal of Rheumatology · 2026